stoxline Quote Chart Rank Option Currency Glossary
  
FOXO Technologies Inc. (FOXO)
0.345  -0.007 (-1.99%)    05-28 16:00
Open: 0.38
High: 0.435
Volume: 2,596,275
  
Pre. Close: 0.352
Low: 0.33
Market Cap: 3(M)
Technical analysis
2024-05-28 4:22:34 PM
Short term     
Mid term     
Targets 6-month :  0.43 1-year :  0.5
Resists First :  0.36 Second :  0.43
Pivot price 0.29
Supports First :  0.26 Second :  0.22
MAs MA(5) :  0.31 MA(20) :  0.29
MA(100) :  0.3 MA(250) :  0.94
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  49.7 D(3) :  48.2
RSI RSI(14): 64
52-week High :  5.28 Low :  0.25
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ FOXO ] has closed below upper band by 0.2%. Bollinger Bands are 14.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.44 - 0.44 0.44 - 0.44
Low: 0.33 - 0.33 0.33 - 0.33
Close: 0.34 - 0.34 0.34 - 0.35
Company Description

FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.

Headline News

Fri, 10 May 2024
Auxly Cannabis Group (OTCMKTS:CBWTF) and FOXO Technologies (NYSE:FOXO) Critical Contrast - Defense World

Tue, 23 Apr 2024
FOXO Technologies Faces NYSE Compliance Challenge - TipRanks.com - TipRanks

Tue, 23 Apr 2024
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements - GlobeNewswire

Fri, 16 Feb 2024
FOXO Technologies Eyes Merger, Secures ClearThink Financing - TipRanks.com - TipRanks

Wed, 14 Feb 2024
FOXO Technologies to merge with M2i Global By Investing.com - Investing.com

Wed, 14 Feb 2024
FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 0 (M)
Shares Float 6 (M)
Held by Insiders 2.89e+006 (%)
Held by Institutions 46 (%)
Shares Short 72 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -3.946e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -41 %
Return on Assets (ttm) 433.3 %
Return on Equity (ttm) -93.5 %
Qtrly Rev. Growth 457000 %
Gross Profit (p.s.) -41.44
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -17.4 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -15 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0.38
Stock Dividends
Dividend 0
Forward Dividend 243680
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android